Tech Company Financing Transactions

Halda Therapeutics Funding Round

Halda Therapeutics closed a $126 million Series B funding round on 8/12/2024. Investors included Access Biotechnology, Boxer Capital and Canaan Partners.

Transaction Overview

Company Name
Halda Therapeutics
Announced On
8/12/2024
Transaction Type
Venture Equity
Amount
$126,000,000
Round
Series B
Investors

Access Biotechnology

Boxer Capital

Canaan Partners

Connecticut Innovations

Deep Track Capital (Rebecca Luse)

Elm Street Ventures

Frazier Life Sciences (Joe Cabral)

RA Capital Management (Nandita Shangari)

Taiho Ventures

Vida Ventures (Arjun Goyal)

Proceeds Purpose
The company intends to use the funds to advance two RIPTAC candidates into clinical trials for patients with prostate cancer and breast cancer, initially in the metastatic setting where drug resistance to standard of care is prevalent.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
115 Munson Street 101
New Haven, CT 06511
USA
Phone
475-210-0212
Website
www.haldatx.com
Email Address
[email protected]
Overview
At Halda, we envision a future where cancer is curable. Halda means "to hold" in old Nordic languages. It represents the way that Halda's novel therapeutic mechanism holds two proteins together in a tightly regulated manner, resulting in cancer-targeted loss of a function essential to cell survival.
Profile
Halda Therapeutics LinkedIn Company Profile
Social Media
Halda Therapeutics Company Twitter Account
Company News
Halda Therapeutics News
Facebook
Halda Therapeutics on Facebook
YouTube
Halda Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Tim Shannon
  Tim Shannon LinkedIn Profile  Tim Shannon Twitter Account  Tim Shannon News  Tim Shannon on Facebook
Chief Financial Officer
Scott Phillips
  Scott Phillips LinkedIn Profile  Scott Phillips Twitter Account  Scott Phillips News  Scott Phillips on Facebook
Chief Scientific Officer
Kat Kayser-Bricker
  Kat Kayser-Bricker LinkedIn Profile  Kat Kayser-Bricker Twitter Account  Kat Kayser-Bricker News  Kat Kayser-Bricker on Facebook

 

 

Browse more venture capital transactions:

Prev: 8/12/2024: Gaussion venture capital transaction
Next: 8/12/2024: Lukka venture capital transaction

 

Share this article

 

Where The Data Comes From

We report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.